Propanc Biopharma share price logo

Propanc Biopharma

NASDAQ: PPCB

$1.01

-0.02

(-1.94%)

Live

as on

Propanc Biopharma Stock Performance

as on September 4, 2026 at 2:06 am IST

  • Day's Low

    Day's High

    $0.97
    $1.03
    downward going graph

    3.96%

    Downside

    1.98%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.95
    $77.49
    downward going graph

    5.94%

    Downside

    7571.78%

    Upside

    downward going graph

Propanc Biopharma share price movements today

Previous Close
$1.03
Open
$1.02
Volume
178.0K
Market Cap
$3.1M
Day's Low - High
$0.97 - $1.03
52 Week Low - High
$0.95 - $77.49

Propanc Biopharma Historical Returns

1 Month Return
+ 11.88 %
3 Month Return
-36.16 %
1 Year Return
-98.34 %
3 Year Return
-100 %
5 Year Return
0 %

Propanc Biopharma Stock Fundamentals & Key Indicators

Check Propanc Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1M

EPS (TTM)

-33

Dividend Yield

0.00%

PE Ratio (TTM)

-0.04

Industry PE ratio

-3.8331543624161073

PEG Ratio

-0.000057938464145353574

Return On Equity TTM

-148.23%

Propanc Biopharma Stock Valuation

Track how Propanc Biopharma P/E has moved over time to understand its valuation trends.

Propanc Biopharma in the last 5 years

  • Overview

  • Trends

Lowest (-0.30x)

June 30, 2023

Industry (-3.83x)

June 30, 2025

Today (-0.28x)

June 30, 2025

Highest (-0.00x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: -0.28x

Propanc Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Propanc Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$3.1MNA-0.040.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Propanc Biopharma Stock including INR - Dollar returns

The Propanc Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Propanc Biopharma investment value today

Current value as on today

₹1,587

Returns

-₹98,413

(-98.41%)

Returns from Propanc Biopharma Stock

-₹98,520 (-98.52%)

Dollar Impact

₹108 (+0.11%)

Indian Investors' Interest in Propanc Biopharma Stock

Investment in Propanc Biopharma Shares on INDmoney has grown by 1491.66% in the last 30 days, indicating increased investment activity.

Time period: to

Change:1491.66% versus previous 30 day period

Search interest for Propanc Biopharma Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:133% versus previous 30 day period

Propanc Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
0
0
0
0
0
-53
-3
-4
-3
-6
EBITDA
0
0
0
0
0
-53
-3
-4
-3
-6
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
-
-
0
0
0
0
0
0
0
Income Before Tax
0
0
0
0
0
-54
-4
-4
-3
-6
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
0
0
0
0
0
-54
-4
-4
-3
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Propanc Biopharma Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Sep 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
0
0
0
-
Operating Income
-5
-3
-2
-3
-1
-1
-1
-1
-57
EBITDA
-4
-4
-4
-3
-1
-2
-2
-1
-58
Interest Expense
3
2
1
1
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-7
-5
-4
-2
-2
-2
-1
-58
Income Tax Expense
0
0
0
0
0
0
0
0
-
Net Income
-7
-7
-5
-4
-2
-2
-2
-1
-58
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Propanc Biopharma Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
0
0
0
0
-54
-4
-4
-3
-6
Operating Cash Flow
0
0
0
0
0
0
0
-1
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
2
0
0
Change in Cash
0
0
0
0
0
0
0
0
0
0

Propanc Biopharma Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Sep 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-7
-7
-5
-4
-2
-2
-2
-1
-58
Operating Cash Flow
-2
-2
-2
-1
-1
-1
-1
0
0
Investing Cash Flow
-
-
0
-
-
-
-
-
-
Financing Cash Flow
2
2
2
1
1
1
1
0
0
Change in Cash
-
-
-
-
0
0
0
0
0

Global Institutional Holdings in Propanc Biopharma

Funds
Holdings
TWO SIGMA SECURITIES, LLC
0%
UBS Group AG
0.32%
Marex Group PLC
0.12%
Sassicaia Capital Advisers LLC
0.03%
XTX Topco Ltd
0.02%

Insights on Propanc Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 134.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 625.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PPCB stock has moved down by -53.8%

About Propanc Biopharma

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.
OrganisationPropanc Biopharma
Headquarters302, 6 Butler Street, Camberwell, VIC, Australia, 3124
IndustryBiotechnology
CEOMr. James Nathanielsz
E-voting on sharesClick here to vote

Key Management of Propanc Biopharma

Name

Title

Mr. James Nathanielsz

CEO & Executive Chairman

Ms. Jeannine Zimmerman

Chief Financial Officer

FAQs

What is Propanc Biopharma share price today?

Propanc Biopharma share price today is $1.01 as on . Propanc Biopharma share today touched a day high of $1.03 and a low of $0.97.

What is the 52 week high and 52 week low for Propanc Biopharma share?

Propanc Biopharma share touched a 52 week high of $77.49 on and a 52 week low of $0.95 on . Propanc Biopharma stock price today i.e. is trending at $1.01,which is 98.70% down from its 52 week high and 6.32% up from its 52 week low.

What is Propanc Biopharma's market capitalisation today?

Propanc Biopharma market capitalisation is $0.00T as on .

How to invest in Propanc Biopharma Stock (PPCB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Propanc Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Propanc Biopharma Shares that will get you 1.4851 shares as per Propanc Biopharma share price of $1.01 per share as on September 3, 2026 at 8:36 pm IST.

What is the minimum amount required to buy Propanc Biopharma Stock (PPCB) from India?

Indian investors can start investing in Propanc Biopharma (PPCB) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Propanc Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Propanc Biopharma share’s latest price of $1.01 as on September 3, 2026 at 8:36 pm IST, you will get 9.9010 shares of Propanc Biopharma. Learn more about fractional shares .